Beacon Bridge Wealth Partners’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Beacon Bridge Wealth Partners’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,000	Closed	-$150K	–	95
2022 Q4	$150K	Buy	+10,000	New	+$138K	0.11%	93

Beacon Bridge Wealth Partners's AVEO Position: Q1 2023 in Review

Beacon Bridge Wealth Partners sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 10,000 shares — an estimated $150K sold.

Beacon Bridge Wealth Partners first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $150K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Beacon Bridge Wealth Partners reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Beacon Bridge Wealth Partners sold 10,000 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $150K.
Beacon Bridge Wealth Partners first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Beacon Bridge Wealth Partners's AVEO Pharmaceuticals, Inc. position peaked at $150K in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Beacon Bridge Wealth Partners's 13F filing for Q1 2023, filed 8 May 2023.